Illumina, Inc. - Common Stock · Transaction Oct 31, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
XNAS · ILMN
-1.99% · -$5.50 · Vol 1.9M
After hours · updated 16:55:29 ET
Illumina Inc
LABORATORY ANALYTICAL INSTRUMENTS
$271.18
Follow $ILMN
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ILMN by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredTue Oct 13 · session closed · Markets closed · resumes Wed 9:30 ET · ILMN
MethodologyILMN
Illumina Inc
Tue Oct 13 · session closed · Markets closed · resumes Wed 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
74/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Tue Oct 13 · session closed · Markets closed · resumes Wed 9:30 ET
AI Analysis
SovereignWhy is ILMN moving today?
Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Illumina Inc
LABORATORY ANALYTICAL INSTRUMENTSListed since
2000
Employees
9K
Country
US
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$276.58
Day high
$276.85
Day low
$267.27
Previous close
$276.67
52W high
$293.69
-7.67% from high
52W low
$91.00
89% of range
Market cap
$41.8B
Beta
0.82
Shares out
151M
Volume
1.9M
0.52× rel vol
Avg volume
3.6M
VWAP
$272.02
Price history computed in-house
1W
-0.86%
1M
+31.35%
3M
+44.90%
1Y
+185.36%
YTD
+106.75%
SMA 50 $229.81 · above
SMA 200 $167.65 · above
52W position 89%
ILMN overview
Related filings and maps
Public disclosures
Congress activity in ILMN
12 filers · 23 buys · 25 sells (0 labeled S (partial)) · Jan 27, 2015 to Feb 10, 2026 · House 46 / Senate 2
All available history · Latest 5 of 48 lines · Read Oct 13, 2026, 9:34 PM UTC
Official filing ↗
Illumina, Inc. - Common Stock · Transaction Oct 30, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
Illumina, Inc. - Common Stock · Transaction Oct 30, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
Illumina, Inc. - Common Stock · Transaction Apr 1, 2025 · Filed Apr 18, 2025 · $1,001 to $15,000
Illumina, Inc. - Common Stock · Transaction Sep 3, 2024 · Filed Sep 24, 2024 · $15,001 to $50,000
Federal contracts
ILMN contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ILMN in this window.
Lobbying spend
ILMN lobbying filings, year to date.
Registered lobbying filings matched to Illumina Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ILMN in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for ILMN.